VG Life Sciences (VGLS) Short Interest Ratio & Short Volume

Short interest is the volume of VG Life Sciences shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 6,949,300 shares of VGLS short. Learn More on VG Life Sciences' current short interest.

VG Life Sciences saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 6,949,300 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to VG Life Sciences: Notable Labs, Ltd. (0.05%), CNS Pharmaceuticals, Inc. (0.49%), Salarius Pharmaceuticals, Inc. (6.72%), Clearmind Medicine Inc. (6.12%), Dermata Therapeutics, Inc. (1.73%), Lucy Scientific Discovery Inc. (2.95%), Altamira Therapeutics Ltd. (28.13%), Qualigen Therapeutics, Inc. (1.74%), Galmed Pharmaceuticals Ltd. (1.10%), PainReform Ltd. (1.21%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.50 billion), KLA Co. ($2.53 billion), Lucid Group, Inc. ($2.50 billion), T. Rowe Price Group, Inc. ($1.91 billion), Williams-Sonoma, Inc. ($1.78 billion), Coinbase Global, Inc. ($1.78 billion), HP Inc. ($1.75 billion), Rivian Automotive, Inc. ($1.70 billion), Lumen Technologies, Inc. ($1.58 billion), and Chesapeake Energy Co. ($1.45 billion). View all of the most shorted stocks.

Short selling VGLS is an investing strategy that aims to generate trading profit from VG Life Sciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for VG Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VGLS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VGLS, twice per month. The most recent reporting period available is July, 15 2022.